7 biggest news story of 2025: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), in widespread use to treat diabetes and obesity, have also demonstrated off-label benefits for a multitude of conditions, including cardiovascular disease, hypertension, Parkinsons, Alzheimers and some addictive disorders
How tirzepatide works: the dual-agonist advantage for effective weight loss Most GLP-1 medications work through a single hormonal pathway, stimulating glucagon-like peptide-1 receptors to slow gastric emptying, suppress appetite, and improve insulin sensitivity
This innovative therapy is being studied for its ability to regulate appetite, promote satiety, and influence energy expenditure, aiming to help individuals achieve sustainable weight loss in a safe and controlled manner
Standard semaglutide titration schedule Month 1: 0.25mg once weekly (tolerance assessment) Month 2: 0.5mg once weekly Month 3: 1.0mg once weekly Month 4: 1.7mg once weekly (if needed) Maintenance: 2.4mg once weekly (maximum dose for weight management) This schedule exists to minimize gastrointestinal side effects
MIDDLE EAST GLUTATHIONE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION) TABLE 352
At 5 mg/mL, each unit equals 0.05 mg
